Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic Peripheral Blood Stem Cell Transplant”

360 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 360 results

Testing effectiveness (Phase 2)Ended earlyNCT01500161
What this trial is testing

Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Lymphocytic Leukemia+6 more
Texas Oncology Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT00262886
What this trial is testing

Donor Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Relapsed or Refractory Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
University of Rochester 35
Early research (Phase 1)Not Yet RecruitingNCT06900192
What this trial is testing

Allogeneic Hematopoietic Cell Transplantation for Primary Progressive Multiple Sclerosis

Who this might be right for
Primary Progressive Multiple SclerosisMultiple SclerosisMultiple Sclerosis, Primary Progressive+1 more
Stanford University 10
Very early researchStudy completedNCT02117115
What this trial is testing

Abdominal CT to Predict the Risk of Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic+1 more
Washington University School of Medicine 21
Testing effectiveness (Phase 2)Study completedNCT00064311
What this trial is testing

Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
National Institutes of Health Clinical Center (CC)
Testing effectiveness (Phase 2)WithdrawnNCT00025519
What this trial is testing

Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney Cancer

Who this might be right for
Kidney Cancer
Fox Chase Cancer Center
Not applicableStudy completedNCT04506320
What this trial is testing

Novel Drugs After Allo-HSCT in Patients With Multiple Myeloma

Who this might be right for
Multiple MyelomaStem Cell Transplant
Gruppo Italiano Trapianto di Midollo Osseo 202
Testing effectiveness (Phase 2)Study completedNCT00060424
What this trial is testing

Fludarabine Phosphate and Total-Body Irradiation Before Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia

Who this might be right for
B-Cell Prolymphocytic LeukemiaChronic Lymphocytic LeukemiaProlymphocytic Leukemia+4 more
Fred Hutchinson Cancer Center 21
Early research (Phase 1)Study completedNCT03885947
What this trial is testing

VPA Expanded UCB Transplantation for Treatment of Patients With Hematological Malignancies

Who this might be right for
Hematological MalignancyAcute Leukemia in RemissionAcute Lymphoblastic Leukemia in Remission+3 more
Alla Keyzner 7
Testing effectiveness (Phase 2)Study completedNCT00427765
What this trial is testing

Busulfan Plus Melphalan Conditioning Regimen for Lymphoid Malignancies or Multiple Myeloma

Who this might be right for
Multiple MyelomaLymphoma
M.D. Anderson Cancer Center 168
Testing effectiveness (Phase 2)WithdrawnNCT00101140
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission

Who this might be right for
Adult Acute Erythroid LeukemiaAdult Acute Monoblastic and Acute Monocytic LeukemiaAdult Acute Myeloid Leukemia
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00020176
What this trial is testing

Allogeneic Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Institute (NCI)
Early research (Phase 1)Looking for participantsNCT05473910
What this trial is testing

T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation

Who this might be right for
AMLMDS
TScan Therapeutics, Inc. 310
Testing effectiveness (Phase 2)Study completedNCT00693927
What this trial is testing

Nonmyeloablative Stem Cell Transplantation With CD8-depleted or Unmanipulated Peripheral Blood Stem Cells (PBSC)

Who this might be right for
Hematologic Malignancies
University of Liege 54
Not applicableNot Yet RecruitingNCT07563920
What this trial is testing

TBF Conditioning Regimen for Haploidentical Stem Cell Transplantation in Elderly AML Patients in First Complete Remission

Who this might be right for
Acute Myeloid Leukemia
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 93
Testing effectiveness (Phase 2)Study completedNCT00506129
What this trial is testing

Allogeneic Transplantation in Patients With Cutaneous T-Cell Lymphoma

Who this might be right for
LymphomaDisorder Related to Bone Marrow Transplantation
M.D. Anderson Cancer Center 33
Early research (Phase 1)Study completedNCT00001765
What this trial is testing

Stem Cell Transplant Following Low-Intensity Chemotherapy to Treat Chronic Granulomatous Disease

Who this might be right for
Chronic Granulomatous Disease
National Institute of Allergy and Infectious Diseases (NIAID) 60
Very early researchActive Not RecruitingNCT03910452
What this trial is testing

Haploidentical Transplant for People With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Busulfan and TBI With Post-Transplant Cyclophosphamide

Who this might be right for
Chronic Granulomatous Disease
National Institute of Allergy and Infectious Diseases (NIAID) 4
Not applicableStudy completedNCT00003538
What this trial is testing

Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Study completedNCT00282282
What this trial is testing

Tacrolimus and Sirolimus as Prophylaxis After Allogenic Non-myeloablative Peripheral Blood Stem Cell Transplantation

Who this might be right for
Graft Versus Host DiseaseGVHD
Dana-Farber Cancer Institute 31
Next Page